MOUNTAIN VIEW, Calif., April 25, 2022 /PRNewswire/ -- Adge Pharmaceuticals ("Adge") has entered into a license agreement with Korea-based Cyan Bio, Inc. ("Cyan"). Cyan will receive exclusive rights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results